Dongsheng Pharmaceutical International Financials
We urge to utilize Dongsheng Pharmaceutical fundamental analysis to find out if markets are presently mispricing the company. Put another way you can exercise it to find out if Dongsheng Pharmaceutical is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze and collect data for twenty-seven available fundamental indicators for Dongsheng Pharmaceutical International, which can be compared to its peers.
Dongsheng |
Understanding current and past Dongsheng Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Dongsheng Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Dongsheng Pharmaceutical's assets may result in an increase in income on the income statement.
The data published in Dongsheng Pharmaceutical's official financial statements usually reflect Dongsheng Pharmaceutical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Dongsheng Pharmaceutical. For example, before you start analyzing numbers published by Dongsheng accountants, it's critical to develop an understanding of what Dongsheng Pharmaceutical's liquidity, profitability, and earnings quality are in the context of the Dongsheng space in which it operates.
Please note, the presentation of Dongsheng Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dongsheng Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Dongsheng Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Dongsheng Pharmaceutical International. Please utilize our Beneish M Score to check the likelihood of Dongsheng Pharmaceutical's management manipulating its earnings.
Dongsheng Pharmaceutical Stock Summary
Dongsheng Pharmaceutical competes with ZhongAn Online, 51Talk Online, AssetMark Financial, Ambipar Emergency, and Cimpress. Dongsheng Pharmaceutical International Co., Ltd.| Instrument | USA OTC BB Equity View All |
| Exchange | OTCBB Exchange |
| Business Address | Dongsheng Pharmaceutical International |
| Benchmark | NYSE Composite |
| Phone | 86 10 8858 0708 |
| Currency | USD - US Dollar |
You should never invest in Dongsheng Pharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Dongsheng OTC BB Equity, because this is throwing your money away. Analyzing the key information contained in Dongsheng Pharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Dongsheng Pharmaceutical Key Financial Ratios
Generally speaking, Dongsheng Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Dongsheng Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Dongsheng Pharmaceutical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Dongsheng Pharmaceutical reports annually and quarterly.Dongsheng Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dongsheng Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Dongsheng Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dongsheng Pharmaceutical competition to find correlations between indicators driving Dongsheng Pharmaceutical's intrinsic value. More Info.Dongsheng Pharmaceutical International is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Dongsheng Pharmaceutical International is roughly 2.45 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Dongsheng Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Dongsheng Pharmaceutical's OTC BB Equity. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dongsheng Pharmaceutical's earnings, one of the primary drivers of an investment's value.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Dongsheng Pharmaceutical information on this page should be used as a complementary analysis to other Dongsheng Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Dongsheng OTC BB Equity
If you are still planning to invest in Dongsheng Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dongsheng Pharmaceutical's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |